220 related articles for article (PubMed ID: 31029489)
21. In vitro activity of cefiderocol and comparators against isolates of Gram-negative bacterial pathogens from a range of infection sources: SIDERO‑WT‑2014-2018 studies in Spain.
Cercenado E; Cardenoso L; Penin R; Longshaw C; Henriksen AS; Pascual A
J Glob Antimicrob Resist; 2021 Sep; 26():292-300. PubMed ID: 34274538
[TBL] [Abstract][Full Text] [Related]
22. Cefiderocol for treatment of an empyema due to extensively drug-resistant
Kufel WD; Steele JM; Riddell SW; Jones Z; Shakeraneh P; Endy TP
IDCases; 2020; 21():e00863. PubMed ID: 32577400
[TBL] [Abstract][Full Text] [Related]
23. Recommendation of a standardized broth microdilution method for antimicrobial susceptibility testing of
Gütgemann F; Heuvelink A; Müller A; Churin Y; Buter R; Jung A; Feberwee A; Wiegel J; Kumm F; Braun AS; Yue M; Soriano-Vargas E; Swanepoel S; Botteldoorn N; Kirchner M; Kehrenberg C
J Clin Microbiol; 2024 Mar; 62(3):e0101123. PubMed ID: 38363142
[TBL] [Abstract][Full Text] [Related]
24. Cefiderocol Antimicrobial Susceptibility Testing against Multidrug-Resistant Gram-Negative Bacilli: a Comparison of Disk Diffusion to Broth Microdilution.
Morris CP; Bergman Y; Tekle T; Fissel JA; Tamma PD; Simner PJ
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 32938734
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of Humanized Exposures of Cefiderocol (S-649266) against a Diverse Population of Gram-Negative Bacteria in a Murine Thigh Infection Model.
Monogue ML; Tsuji M; Yamano Y; Echols R; Nicolau DP
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848004
[TBL] [Abstract][Full Text] [Related]
26. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
27. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
Falagas ME; Skalidis T; Vardakas KZ; Legakis NJ;
J Antimicrob Chemother; 2017 Jun; 72(6):1704-1708. PubMed ID: 28369471
[TBL] [Abstract][Full Text] [Related]
28. Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae.
Ito A; Nishikawa T; Ota M; Ito-Horiyama T; Ishibashi N; Sato T; Tsuji M; Yamano Y
J Antimicrob Chemother; 2018 Nov; 73(11):3049-3052. PubMed ID: 30188999
[TBL] [Abstract][Full Text] [Related]
29. Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens.
Dobias J; Dénervaud-Tendon V; Poirel L; Nordmann P
Eur J Clin Microbiol Infect Dis; 2017 Dec; 36(12):2319-2327. PubMed ID: 28748397
[TBL] [Abstract][Full Text] [Related]
30. Comparative in vitro activities of the novel antibacterial finafloxacin against selected Gram-positive and Gram-negative bacteria tested in Mueller-Hinton broth and synthetic urine.
Dalhoff A; Stubbings W; Schubert S
Antimicrob Agents Chemother; 2011 Apr; 55(4):1814-8. PubMed ID: 21245444
[TBL] [Abstract][Full Text] [Related]
31. Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of
Ballesté-Delpierre C; Ramírez Á; Muñoz L; Longshaw C; Roca I; Vila J
Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203791
[TBL] [Abstract][Full Text] [Related]
32. Multilaboratory Comparison of Omadacycline MIC Test Strip to Broth Microdilution MIC against Gram-Negative, Gram-Positive, and Fastidious Bacteria.
Koeth LK; DiFranco-Fisher JM; Hardy DJ; Palavecino EL; Carretto E; Windau A
J Clin Microbiol; 2022 Jan; 60(1):e0141021. PubMed ID: 34613800
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
[TBL] [Abstract][Full Text] [Related]
34. Proposal of a Method for Harmonized Broth Microdilution Antimicrobial Susceptibility Testing of Avibacterium gallinarum.
Gütgemann F; Müller A; Churin Y; Jung A; Kumm F; Heuvelink A; Yue M; Kehrenberg C
J Clin Microbiol; 2022 Aug; 60(8):e0041922. PubMed ID: 35852371
[No Abstract] [Full Text] [Related]
35. Elucidating the effect of iron acquisition systems in Klebsiella pneumoniae on susceptibility to the novel siderophore-cephalosporin cefiderocol.
Daoud L; Al-Marzooq F; Moubareck CA; Ghazawi A; Collyns T
PLoS One; 2022; 17(12):e0277946. PubMed ID: 36580460
[TBL] [Abstract][Full Text] [Related]
36. Performance of discs, sensititre EUMDROXF microplates and MTS gradient strips for the determination of the susceptibility of multidrug-resistant Pseudomonas aeruginosa to cefiderocol.
Devoos L; Biguenet A; Rousselot J; Bour M; Plésiat P; Fournier D; Jeannot K
Clin Microbiol Infect; 2023 May; 29(5):652.e1-652.e8. PubMed ID: 36587736
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Clostridium difficile minimum inhibitory concentrations obtained using agar dilution vs broth microdilution methods.
Hastey CJ; Dale SE; Nary J; Citron D; Law JH; Roe-Carpenter DE; Chesnel L
Anaerobe; 2017 Apr; 44():73-77. PubMed ID: 28188880
[TBL] [Abstract][Full Text] [Related]
38. Assessment of cefiderocol disk diffusion versus broth microdilution results when tested against
Liu Y; Ding L; Han R; Zeng L; Li J; Guo Y; Hu F
Microbiol Spectr; 2023 Dec; 11(6):e0535522. PubMed ID: 37855593
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Humanized Cefiderocol Exposure Is Unaltered by Host Iron Overload in the Thigh Infection Model.
Kidd JM; Abdelraouf K; Nicolau DP
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658966
[TBL] [Abstract][Full Text] [Related]
40. Disc Diffusion and ComASP
Bianco G; Boattini M; Comini S; Banche G; Cavallo R; Costa C
Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
